companydata.dkBIOSYNTIA ApS: Financial statements 2019
CVR: 34892970
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 439,331 and a net result of DKK -8,227,909 compared with DKK -9,431,042 the year before. Equity amounted to DKK 16,939,867. The solvency ratio was 89.3%. The company had 20 employees in the financial year.
- Gross Profit
- 439,331 kr.
- Profit/Loss
- -8,227,909 kr.
- Equity
- 16,939,867 kr.
- Total Assets
- 18,965,646 kr.
- Employees
- 20
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 439 t. | -8.2 mio. | 16.9 mio. | 20 |
| 2018 | - | -2.7 mio. | -9.4 mio. | 25.2 mio. | 18 |
| 2017 | - | 2.2 mio. | -3.2 mio. | 4.8 mio. | 14 |
| 2016 | - | 619 t. | -2.8 mio. | 8 mio. | 8 |
| 2015 | - | 1.2 mio. | -1.7 mio. | 3.9 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
As of December 6, 2019, Thomas Grotkjær has joined the board of directors of BIOSYNTIA ApS.
As of December 6, 2019, Søren Møller has left the board of directors of BIOSYNTIA ApS.
BIOSYNTIA ApS has published its annual report for 2018. Gross profit came to DKK -2,671,636, and the net result was DKK -9,431,042.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees. In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity amounted to DKK 32,860,576.